bell
The current prices are delayed by 15 mins, login to check live prices.
Ipca Laboratories Ltd share price logo

Ipca Laboratories Ltd Share Price

(IPCALAB)

₹1543.250.45%

as on 04:01PM, 17 Jan 2025

Overview
News
Financials
Q3 2024 Results
Technicals
F&O

Ipca Laboratories Ltd Analyst Rating

based on 20 analysts

BUY

60.00%

Buy

15.00%

Hold

25.00%

Sell

Based on 20 analysts offering long term price targets for Ipca Laboratories Ltd. An average target of ₹1591.05

Source: S&P Global Market Intelligence

Ipca Laboratories Ltd Share analysis

Ipca Laboratories Ltd price forecast by 20 analysts

Upside of3.10%

High

₹1970

Target

₹1591.05

Low

₹900

Ipca Laboratories Ltd target price ₹1591.05, a slight upside of 3.1% compared to current price of ₹1543.25. According to 20 analysts rating.

Source: S&P Global Market Intelligence

Ipca Laboratories Ltd Performance

  • Day's Low

    Day's High

    ₹1,528
    Day's Price Range
    ₹1,549
  • 52 Week's Low

    52 Week's High

    ₹1,052
    52-Week Price Range
    ₹1,755.9
1 Month Return-2.48 %
3 Month Return-4.4 %
1 Year Return+ 43.2 %
Previous Close₹1,550.30
Open₹1,542.50
Volume1.75L
Upper Circuit-
Lower Circuit-
Market Cap₹39,152.90Cr

Ipca Laboratories Ltd Key Statistics

P/E Ratio59.2
PEG Ratio8.89
Market Cap₹39,152.90 Cr
P/B Ratio4.95
EPS20.86
Dividend Yield0.32
SectorPharmaceuticals
ROE9.81

Ipca Laboratories Ltd Peer Comparison

Company
Analyst ViewMarket Cap5 Year CAGRDebt to Asset RatioNet ProfitYearly Revenue
BUY₹39,152.90 Cr30.62%0.58₹529 Cr₹7,705 Cr
BUY₹12,523.02 Cr-3.67%0.52₹602 Cr₹2,851 Cr
BUY₹69,044.08 Cr28.8%0.56₹3,168 Cr₹29,001 Cr
HOLD₹1,00,085.06 Cr54.52%0.64₹3,854 Cr₹19,547 Cr
BUY₹59,350.61 Cr24.18%0.53NANA

About Ipca Laboratories Ltd

Ipca Laboratories is a fully integrated global pharmaceutical company, manufacturing and marketing over 350 formulations and 80 APIs in over 100 countries around the world. Established in 1949, with its original name as Indian Pharmaceutical Combine Association Limited, Ipca has 17 manufacturing units in India, producing APIs and Formulations that are approved by major drug regulatory authorities, including the US FDA, UK MHRA, South African MCC, Brazilian ANVISA and Australian TGA. Apart from native India, Ipca is also a recognized supplier of intermediates and APIs⁠—Atenolol, Chloroquine Phosphate, Furosemide, and Pyrantel Salts⁠—globally. Ipca has received accreditation from ISO 9001, Forbes Global 200 best small companies, WHOGMP, INVIMA Colombian, and German standards, making it a respected name in the pharmaceutical industry. Recently, Ipca has acquired a number of companies, namely Krebs Biochemicals and Industries Ltd., Pisgah Labs Inc., Trophic Wellness Private Ltd, Lyka Labs Limited, and M/s. Ramdev Chemical Private Limited, to further extend its presence in the global market.

Share Price: ₹1543.25 per share as on 17 Jan, 2025 04:01 PM
Market Capitalisation: ₹39,152.90Cr as of today
Revenue: ₹2,354.90Cr as on September 2024 (Q3 24)
Net Profit: ₹245.44Cr as on September 2024 (Q3 24)
Listing date: 03 Nov, 1994
Chairperson Name: Premchand Godha
OrganisationIpca Laboratories Ltd
HeadquartersMumbai
IndustryPharmaceuticals
E-voting on sharesClick here to vote

Key events for Ipca Laboratories Ltd

  • Ipca Laboratories Set for Strong Turnaround - 14 Jan, 2025

    Ipca Laboratories is expected to experience a strong turnaround driven by a revival in its US business, new product launches, and growth in ex-US markets. The company is expanding into fast-growing therapies domestically and is projected to achieve a 27% earnings CAGR over FY24-27, supported by operational efficiencies and Unichem synergies.
  • Ipca Laboratories Stock Shows Strong Upward Potential - 08 Jan, 2025

    Ipca Laboratories stock is recommended for buying at ₹1,736, with a target of ₹1,805-1,825. The stock is near its lifetime high, indicating potential for further gains.
  • Ipca Laboratories Hits All-Time High Stock Price - 03 Jan, 2025

    On January 3, 2025, Ipca Laboratories reached an all-time high of Rs. 1757.65, reflecting a 56.29% increase over the past year, significantly outperforming the Sensex. The stock has shown strong momentum with seven consecutive days of gains and is trading above key moving averages.
  • Ipca Laboratories Hits New Highs in January 2025 - 02 Jan, 2025

    On January 2, 2025, Ipca Laboratories reached an all-time high and a new 52-week high, showcasing strong performance with significant gains over six days and a remarkable annual return.
  • Ipca Laboratories Hits New High, Positive Analyst Outlook - 01 Jan, 2025

    Ipca Laboratories achieved a new 52-week high of Rs 1709.95, reflecting a 49.62% annual growth. Motilal Oswal set a target price of Rs 1980, recommending a buy. The stock rose 0.49% for the fifth consecutive session, indicating strong momentum.
  • Ipca Laboratories Targeted for Growth and Revival - 30 Dec, 2024

    Motilal Oswal has reiterated a buy rating for Ipca Laboratories with a target price of Rs 1,980, highlighting strong growth in US operations and domestic therapies. The company is expanding its divisions and expects a 27% earnings CAGR over FY24-27, driven by synergies from the Unichem acquisition.
  • Ipca Laboratories Shows Bullish Potential - 28 Dec, 2024

    Ipca Laboratories is expected to experience a significant upside, with a 92.09% rollover and a breakout on the technical front. The stock may test levels of Rs 1730 and Rs 1800 in the short term.
  • Ipca Laboratories Focuses on Sustained Earnings Growth - 24 Dec, 2024

    Ipca Laboratories is committed to maintaining strong earnings momentum over the next 2-3 years, driven by product relaunches in the US, new offerings, and synergies with Unichems.
  • IPCA Labs Anticipates Growth and Improved Margins - 23 Dec, 2024

    IPCA Laboratories expects EBITDA margins to rise to 21% due to a healthy product mix and raw material cost optimization. Strong growth in the domestic formulation business and opportunities in the API space support positive earnings outlook, with a projected stock price target of Rs 1,918 in 8 to 10 months.
  • IPCA Labs Sees Stake Sale Amid Stock Gains - 19 Dec, 2024

    IPCA Laboratories shares gained up to 6% despite a promoter selling 1.6% stake for ₹600 crore. The stock has risen 44% in 2024.
  • Ipca Laboratories Promoter Divests 1.6% Stake - 18 Dec, 2024

    Usha Madhukar Chandurkar, a promoter of Ipca Laboratories, divested a 1.6% stake for Rs 600 crore, decreasing promoter holdings from 46.3% to 44.7%. Following the sale, shares fell 2.68% to Rs 1,516.05.

Insights on Ipca Laboratories Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    MF Holding Up

    img

    Mutual Funds have increased holdings from 28.55% to 29.63% in Dec 2024 quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 month, IPCALAB stock has moved up by 0.9%

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 3 quarters, 2.05K Cr → 2.38K Cr (in ₹), with an average increase of 7.1% per quarter

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 3 quarters, 59.59 Cr → 229.48 Cr (in ₹), with an average increase of 42.6% per quarter

  • imgPOSITIVE IMPACT

    FII Holding Up

    img

    Foreign Institutions have increased holdings from 10.83% to 11.07% in Dec 2024 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Divis Laboratories Ltd has given 46.6% return, outperforming this stock by 8.0%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Sun Pharmaceuticals Industries Ltd has given 103.2% return, outperforming this stock by 54.5%

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 8.64% to 8.53% in Dec 2024 quarter

  • imgNEGATIVE IMPACT

    Promoter Holding Down

    img

    Promoters have decreased holdings from 46.30% to 44.72% in Dec 2024 quarter

Ipca Laboratories Ltd Financials

Value in ₹ crore
DetailsQ'3 23Q'4 23Q'1 24Q'2 24Q'3 24
Revenue₹2,033.96Cr (-)₹2,052.86Cr (↑0.93%)₹2,033.03Cr (↓0.97%)₹2,092.63Cr (↑2.93%)₹2,354.90Cr (↑12.53%)
Net Income₹137.44Cr (-)₹222.65Cr (↑62.00%)₹2.91Cr (↓98.69%)₹198.98Cr (↑6,737.80%)₹245.44Cr (↑23.35%)
Net Profit Margin6.76% (-)10.85% (↑60.50%)0.14% (↓98.71%)9.51% (↑6,692.86%)10.42% (↑9.57%)
Value in ₹ crore
Details2021202220232024
Total Assets₹6,098.57Cr (-)₹7,539.92Cr (↑23.63%)₹8,465.49Cr (↑12.28%)₹8,682.44Cr (↑2.56%)
Total Liabilities₹1,345.85Cr (-)₹2,064.16Cr (↑53.37%)₹2,588.19Cr (↑25.39%)₹2,333.73Cr (↓9.83%)
Value in ₹ crore
Details20202021202220232024
Operating Cash Flow₹561.43Cr (-)₹1,096.06Cr (↑95.23%)₹831.72Cr (↓24.12%)₹762.29Cr (↓8.35%)₹830.51Cr (↑8.95%)

Index Inclusions

BSE Healthcare

₹42,660.26

0.22 (95.19%)

S&P BSE 250 LargeMidCap

₹10,088.08

-0.17 (-17.11%)

S&P BSE 400 MidSmallCap

₹11,515.38

0.04 (4.9%)

Nifty 500

₹21,680.25

-0.16 (-34.3%)

Nifty MidSmallcap 400

₹18,978.85

0.06 (10.9%)

Nifty Healthcare

₹14,057.75

0.43 (60.65%)

NIFTY PHARMA

₹22,061.70

0.69 (151.95%)

BSE Mid-Cap

₹43,761.23

0.04 (17.54%)

BSE 200

₹10,639.68

-0.17 (-18.25%)

S&P BSE AllCap

₹10,471.31

0.68 (71.07%)

S&P BSE 150 MidCap

₹15,138.10

0.09 (13.37%)

BSE 500

₹34,083.34

-0.16 (-53.44%)

Nifty Midcap 150

₹20,195.90

0.12 (23.25%)

Nifty LargeMidcap 250

₹15,180.20

-0.07 (-10.05%)

Ipca Laboratories Ltd Shareholding Pattern

InvestorsHoldings %FY Quarter3M change
Promoter Holdings
44.72%
-3.41
Foreign Institutions
11.07%
2.20
Mutual Funds
29.63%
3.80
Retail Investors
8.53%
-1.30
Others
6.04%
6.46

Ipca Laboratories Ltd Key Indicators

Details20202021202220232024
Book Value Per Share (₹)143.07185.33215.41230.27249.59
Details20202021202220232024
Earning Per Share (₹)23.8945.2935.9119.3920.86
Details20202021202220232024
Return On Equity %19.1527.0616.828.919.81
Details20202021202220232024
Return On Assets %11.518.6911.735.576.3

Ipca Laboratories Ltd Valuation

Ipca Laboratories Ltd in the last 5 years

  • Overview

  • Trends

Lowest (18.72x)

October 10, 2019

Industry (54.95x)

January 17, 2025

Today (59.20x)

January 17, 2025

Highest (66.90x)

January 2, 2025

LowHigh

Ipca Laboratories Ltd Earnings and Dividends

  • Ipca Laboratories Ltd Earnings Results

    Ipca Laboratories Ltd’s net profit jumped 58.2% since last year same period to ₹229.48Cr in the Q2 2024-2025. On a quarterly growth basis, Ipca Laboratories Ltd has generated 19.37% jump in its net profits since last 3-months.

    Read More about Earnings Results
  • Ipca Laboratories Ltd Dividends November,2024

    In the quarter ending September 2024, Ipca Laboratories Ltd has declared dividend of ₹2 - translating a dividend yield of 0.26%.

    Read More about Dividends

Ipca Laboratories Ltd Technicals Summary

Bearish

Neutral

Bullish

Bearish

Ipca Laboratories Ltd is currently in a Bearish trading position according to technical analysis indicators.

FAQs on Ipca Laboratories Ltd

Ipca Laboratories Ltd share price today stands at ₹1543.25, Open. ₹1542.5 ; Previous Close. ₹1550.3 ; High. ₹1549 ; Low. ₹1528 ; 52 Week High. ₹1755.9 ; 52 Week Low: ₹1052.

  • Get a PAN card.
  • Open a Demat account.
  • Open a Trading account.
  • Link your Demat account to your Trading account.
  • Fund your Trading account.
  • Place an order to buy Ipca Laboratories Ltd shares.

Ipca Laboratories Ltd is listed on NSE

Ipca Laboratories Ltd is listed on BSE

  • Today’s highest price of Ipca Laboratories Ltd is ₹1549.
  • Today’s lowest price of Ipca Laboratories Ltd is ₹1528.

PE Ratio of Ipca Laboratories Ltd is 59.2

PE ratio = Ipca Laboratories Ltd Market price per share / Ipca Laboratories Ltd Earnings per share

Today’s traded volume of Ipca Laboratories Ltd(IPCALAB) is 1.75L.

Today’s market capitalisation of Ipca Laboratories Ltd(IPCALAB) is ₹39152.9Cr.

Ipca Laboratories Ltd(IPCALABPrice
52 Week High
₹1755.9
52 Week Low
₹1052

Ipca Laboratories Ltd(IPCALAB) share price is ₹1543.25. It is down -12.11% from its 52 Week High price of ₹1755.9

Ipca Laboratories Ltd(IPCALAB) share price is ₹1543.25. It is up 46.70% from its 52 Week Low price of ₹1052

Ipca Laboratories Ltd(IPCALABReturns
1 Day Returns
-7.05%
1 Month Returns
-2.48%
3 Month Returns
-4.4%
1 Year Returns
43.2%